View Article |
There are no differences between factors determining graft infection in autologous bone flap replacement and acrylic cranioplasty: a prospective observational study at Hospital Kuala Lumpur
Siti Azleen Mohamad1, Mohd Safari Mohd Haspani2, Badrisyah Idris3.
Objectives: This study, conducted in 2012, was performed to determine the incidence
of graft infection after cranioplasty procedures and factors affecting the graft infection rate at
Hospital Kuala Lumpur (HKL).
Methodology: This was an observational cross-sectional case study of patients who
have undergone cranioplasty at HKL over a period of one year (2012). One hundred seventytwo
patients were included in the study. A total of 105 (61.8%) cases were autologous bone flap
replacements, and 67 (38.2%) were acrylic cranioplasty.
Result: A total of five infected grafts were identified among the 172 cases included in the
study, resulting in an overall infection rate of 2.9%. Of this infected group, three (4.5%) were
cases of cranioplasty and two (1.9%) were cases of autologous bone flap replacement. There
was high proportion of male patients undergoing cranioplasty (118 [or 68.6%]) and only 54 (or
31.4%) female patients. The primary pathology in the majority of patients (126 [or 73.2%]) was
due to trauma; only 46 cases (or 26.8%) did not result from trauma. Of the patients, 123 (or
71.5%) had undergone a single cranial procedure prior to their cranioplasty, and 43 (or 28.5%)
had undergone multiple cranial procedures. Most of the patients (114 [or 66.3%]) underwent
cranioplasty 90 days after undergoing decompressive craniectomy while 58 (or 33.7%) underwent
cranioplasty less than 90 days after decompressive craniectomy.
Affiliation:
- Hospital Kuala Lumpur, Malaysia
- Hospital Kuala Lumpur, Malaysia
- Universiti Sains Malaysia, Malaysia
Download this article (This article has been downloaded 70 time(s))
|
|
Indexation |
Indexed by |
MyJurnal (2019) |
H-Index
|
0 |
Immediacy Index
|
0.000 |
Rank |
0 |
Indexed by |
Scopus (SCImago Journal Rankings 2016) |
Impact Factor
|
- |
Rank |
Q2 (Medicine (miscellaneous)) |
Additional Information |
0.277 (SJR) |
|
|
|